123 related articles for article (PubMed ID: 24374069)
21. Dopamine D2 receptor stimulation promotes the proliferation of neural progenitor cells in adult mouse hippocampus.
Hiramoto T; Kanda Y; Satoh Y; Takishima K; Watanabe Y
Neuroreport; 2007 May; 18(7):659-64. PubMed ID: 17426594
[TBL] [Abstract][Full Text] [Related]
22. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
[TBL] [Abstract][Full Text] [Related]
23. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
Jutkiewicz EM; Bergman J
J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
[TBL] [Abstract][Full Text] [Related]
24. Dopaminergic modulation of neurogenesis in the subventricular zone of the adult brain.
O'Keeffe GC; Barker RA; Caldwell MA
Cell Cycle; 2009 Sep; 8(18):2888-94. PubMed ID: 19713754
[TBL] [Abstract][Full Text] [Related]
25. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
Ralph RJ; Caine SB
J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
[TBL] [Abstract][Full Text] [Related]
26. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
27. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Tidey JW; Bergman J
J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
[TBL] [Abstract][Full Text] [Related]
28. The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia.
Malik P; Andersen MB; Peacock L
Pharmacol Biochem Behav; 2004 Aug; 78(4):805-10. PubMed ID: 15301939
[TBL] [Abstract][Full Text] [Related]
29. Influence of dopamine on precursor cell proliferation and differentiation in the embryonic mouse telencephalon.
Popolo M; McCarthy DM; Bhide PG
Dev Neurosci; 2004; 26(2-4):229-44. PubMed ID: 15711063
[TBL] [Abstract][Full Text] [Related]
30. Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect.
Verma A; Kulkarni SK; Nayar U
Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):515-25. PubMed ID: 7905945
[TBL] [Abstract][Full Text] [Related]
31. Tonic modulation of inhibition by dopamine D4 receptors in the rat hippocampus.
Romo-Parra H; Aceves J; Gutiérrez R
Hippocampus; 2005; 15(2):254-9. PubMed ID: 15476261
[TBL] [Abstract][Full Text] [Related]
32. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
Filip M; Przegaliński E
Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
[TBL] [Abstract][Full Text] [Related]
33. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
34. Potentiation of dopamine D1-like receptor signaling by concomitant activation of δ- and μ-opioid receptors in mouse medial prefrontal cortex.
Olianas MC; Dedoni S; Onali P
Neurochem Int; 2012 Dec; 61(8):1404-16. PubMed ID: 23073238
[TBL] [Abstract][Full Text] [Related]
35. [Effect of intrathecal injection of dopamine receptor agonists/antagonists on pain and acupuncture analgesia in rats].
Gao X; Xin BM; Zhu CB; Wu GC; Xu SF
Sheng Li Xue Bao; 1998 Feb; 50(1):43-8. PubMed ID: 11324516
[TBL] [Abstract][Full Text] [Related]
36. Effects of the intravitreal administration of dopaminergic ligands on the b-wave amplitude of the rabbit electroretinogram.
Huppé-Gourgues F; Coudé G; Lachapelle P; Casanova C
Vision Res; 2005 Jan; 45(2):137-45. PubMed ID: 15581915
[TBL] [Abstract][Full Text] [Related]
37. Effects of dopamine D1 and D2 receptor agonists and antagonists on basal and ethanol-modulated beta-endorphin secretion from hypothalamic neurons in primary cultures.
Boyadjieva NI; Sarkar DK
J Neuroendocrinol; 1995 Nov; 7(11):819-25. PubMed ID: 8748117
[TBL] [Abstract][Full Text] [Related]
38. Dopamine suppresses stimulus-induced field potentials in layer III of rat medial entorhinal cortex.
Stenkamp K; Heinemann U; Schmitz D
Neurosci Lett; 1998 Oct; 255(2):119-21. PubMed ID: 9835229
[TBL] [Abstract][Full Text] [Related]
39. A selective D2 dopamine receptor agonist alleviates depression through up-regulation of tyrosine hydroxylase and increased neurogenesis in hippocampus of the prenatally stressed rats.
Fatima M; Ahmad MH; Srivastav S; Rizvi MA; Mondal AC
Neurochem Int; 2020 Jun; 136():104730. PubMed ID: 32201282
[TBL] [Abstract][Full Text] [Related]
40. Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size.
Parish CL; Stanic D; Drago J; Borrelli E; Finkelstein DI; Horne MK
Eur J Neurosci; 2002 Sep; 16(5):787-94. PubMed ID: 12372014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
